IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 8,060.00
-20.00 (-0.25%)
Aug 29, 2025, 12:07 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 113.26 billion as of August 28, 2025. Its market cap has decreased by -52.83% in one year.
Market Cap
113.26B
Enterprise Value
89.02B
Revenue
3.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,060.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 113.26B, a decrease of -77.52%. That is a compound annual growth rate of -65.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 114.53B | -23.29% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.63T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,893.98B |
| Peptron | 7,466.80B |
| PharmaResearch | 7,314.31B |
| LigaChem Biosciences | 5,419.69B |